TFS Capital’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-95,987
| Closed | -$1.23M | – | 647 |
|
|
2017
Q1 | $1.23M | Buy |
+95,987
| New | +$1.23M | 0.4% | 36 |
|
|
2016
Q2 | – | Sell |
-122,027
| Closed | -$860K | – | 1002 |
|
|
2016
Q1 | $860K | Buy |
+122,027
| New | +$860K | 0.12% | 291 |
|
|
2015
Q4 | – | Sell |
-366,042
| Closed | -$2.45M | – | 777 |
|
|
2015
Q3 | $2.45M | Sell |
366,042
-533,909
| -59% | -$3.57M | 0.24% | 118 |
|
|
2015
Q2 | $6.05M | Buy |
899,951
+719,285
| +398% | +$4.83M | 0.59% | 9 |
|
|
2015
Q1 | $1.23M | Buy |
180,666
+112,156
| +164% | +$760K | 0.12% | 275 |
|
|
2014
Q4 | $549K | Buy |
68,510
+19,709
| +40% | +$158K | 0.05% | 553 |
|
|
2014
Q3 | $172K | Buy |
48,801
+31,277
| +178% | +$110K | 0.01% | 906 |
|
|
2014
Q2 | $84K | Buy |
+17,524
| New | +$84K | 0.01% | 1062 |
|
|
2014
Q1 | – | Sell |
-553,402
| Closed | -$3.6M | – | 1385 |
|
|
2013
Q4 | $3.6M | Buy |
553,402
+455,746
| +467% | +$2.96M | 0.17% | 173 |
|
|
2013
Q3 | $739K | Buy |
+97,656
| New | +$739K | 0.03% | 696 |
|